Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP873171.RAblrqwR7GjIlnyYncG_3ezYzMkiolg5hcBqrBCCAY7XY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP873171.RAblrqwR7GjIlnyYncG_3ezYzMkiolg5hcBqrBCCAY7XY130_assertion type Assertion NP873171.RAblrqwR7GjIlnyYncG_3ezYzMkiolg5hcBqrBCCAY7XY130_head.
- NP873171.RAblrqwR7GjIlnyYncG_3ezYzMkiolg5hcBqrBCCAY7XY130_assertion description "[From a translational standpoint, hypermethylation can be used as a marker of recurrent disease or progression, for example, in MDS, or response to chemotherapy, such as MGMT methylation in B-cell non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873171.RAblrqwR7GjIlnyYncG_3ezYzMkiolg5hcBqrBCCAY7XY130_provenance.
- NP873171.RAblrqwR7GjIlnyYncG_3ezYzMkiolg5hcBqrBCCAY7XY130_assertion evidence source_evidence_literature NP873171.RAblrqwR7GjIlnyYncG_3ezYzMkiolg5hcBqrBCCAY7XY130_provenance.
- NP873171.RAblrqwR7GjIlnyYncG_3ezYzMkiolg5hcBqrBCCAY7XY130_assertion SIO_000772 14585279 NP873171.RAblrqwR7GjIlnyYncG_3ezYzMkiolg5hcBqrBCCAY7XY130_provenance.
- NP873171.RAblrqwR7GjIlnyYncG_3ezYzMkiolg5hcBqrBCCAY7XY130_assertion wasDerivedFrom befree-20150227 NP873171.RAblrqwR7GjIlnyYncG_3ezYzMkiolg5hcBqrBCCAY7XY130_provenance.
- NP873171.RAblrqwR7GjIlnyYncG_3ezYzMkiolg5hcBqrBCCAY7XY130_assertion wasGeneratedBy ECO_0000203 NP873171.RAblrqwR7GjIlnyYncG_3ezYzMkiolg5hcBqrBCCAY7XY130_provenance.